Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 1
2023 3
2024 2
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.

Mean CST reductions were greater (YOSEMITE/RHINE weeks 92/96/100 average: faricimab every 8 weeks -216.0/-202.6 m, faricimab T&E -204.5/-197.1 m, aflibercept every 8 weeks -196.3/-185.6 m), and more patients achieved absence of DME (CST < 325 mum; YOSE

…
Mean CST reductions were greater (YOSEMITE/RHINE weeks 92/96/100 average: faricimab every 8 weeks -216.0/-202.6 m, faricimab T&E …
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Recent developments in digital light processing 3D-printing techniques for microfluidic analytical devices.
Amini A, Guijt RM, Themelis T, De Vos J, Eeltink S. Amini A, et al. J Chromatogr A. 2023 Mar 15;1692:463842. doi: 10.1016/j.chroma.2023.463842. Epub 2023 Feb 1. J Chromatogr A. 2023. PMID: 36745962 Review.
Advances in vat and lift design, projector technology, and resin composition, allow accurate fabrication of microchannel structures as small as 18 20 m. This review describes the latest advances in DLP 3D-printing technology with respect to instrument set-up and resin form …
Advances in vat and lift design, projector technology, and resin composition, allow accurate fabrication of microchannel structures as small …
Effect of retinoic acid treatment on the retinoic acid signaling pathway in a human siRNA-based aniridia limbal epithelial cell model, in vitro.
Hsu SL, Stachon T, Fries FN, Li Z, Li S, Liu S, Seitz B, Kundu S, Amini M, Suiwal S, Szentmáry N. Hsu SL, et al. PLoS One. 2025 Jun 18;20(6):e0324946. doi: 10.1371/journal.pone.0324946. eCollection 2025. PLoS One. 2025. PMID: 40531840 Free PMC article.

ALDH1A1 mRNA expression was significantly downregulated using 5 M RA treatment in the control group (p = 0.038). CYP26A1 mRNA expression was upregulated using 1 M and 5 M RA treatment in both the PAX6 control (p < 0.001; p < 0.001) and the PAX6 knockdow

…
ALDH1A1 mRNA expression was significantly downregulated using 5 M RA treatment in the control group (p = 0.038). CYP26A1 mRNA express …
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.
Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, Amini N, Aeinehband S; Karolinska Schizophrenia Project (KaSP) consortium; Erhardt S, Halldin C, Flyckt L, Farde L, Cervenka S. Collste K, et al. Mol Psychiatry. 2017 Jun;22(6):850-856. doi: 10.1038/mp.2016.247. Epub 2017 Feb 14. Mol Psychiatry. 2017. PMID: 28194003
Bio-barcode technology for detection of Staphylococcus aureus protein A based on gold and iron nanoparticles.
Amini A, Kamali M, Amini B, Najafi A, Narmani A, Hasani L, Rashidiani J, Kooshki H, Elahi N. Amini A, et al. Int J Biol Macromol. 2019 Mar 1;124:1256-1263. doi: 10.1016/j.ijbiomac.2018.11.123. Epub 2018 Nov 14. Int J Biol Macromol. 2019. PMID: 30445082
Finally, the bio-barcode DNA was released from surface of complex using DTT (0.8 M) and there was isolated of nanoparticles by magnetic field and centrifuge. The fluorescence intensity of bio-barcode DNA was measured in different concentrations of S. aureus (10(1) to 10(8) …
Finally, the bio-barcode DNA was released from surface of complex using DTT (0.8 M) and there was isolated of nanoparticles by magnet …